Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
30 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/09/30/2955179/0/en/Wave-Life-Sciences-to-Present-at-Chardan-8th-Annual-Genetic-Medicines-Conference.html
25 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/26/2953458/0/en/Wave-Life-Sciences-Prices-Upsized-200-Million-Public-Offering-of-Ordinary-Shares-and-Pre-Funded-Warrants.html
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/24/2952590/0/en/Wave-Life-Sciences-Announces-Proposed-Public-Offering-of-Ordinary-Shares-and-Pre-Funded-Warrants.html
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/24/2952057/0/en/Wave-Life-Sciences-Announces-Positive-Interim-Data-from-FORWARD-53-Clinical-Trial-Evaluating-WVE-N531-in-Boys-with-Duchenne-Muscular-Dystrophy-Amenable-to-Exon-53-Skipping.html
12 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/12/2928407/0/en/Wave-Life-Sciences-Receives-FDA-Rare-Pediatric-Disease-Designation-for-WVE-N531-for-the-Treatment-of-Duchenne-Muscular-Dystrophy.html
08 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/08/2926832/0/en/Wave-Life-Sciences-Reports-Second-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?